This inventor holds 18 USPTO granted patents and 2 published patent applications and 4 EPO patents, primarily in Infectious Disease Treatment. Top assignees: Corixa Corporation, Infectious Disease Research Institute, Glaxosmithkline Biologicals Sa. Active years: 2000-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
15 out of 247 
3 out of 34 
1 out of 545 
Years Active: 2000-2016
Areas of Expertise:
Title: The Innovations of Inventor Ajay Bhatia
Introduction: Ajay Bhatia, based in Seattle, WA, has made significant contributions to the field of biotechnology through his innovative inventions. With a remarkable portfolio of 18 patents, he has demonstrated a commitment to advancing diagnostic and treatment methods for various diseases. His work particularly focuses on fusion proteins and their applications in medicine.
Latest Patents: One of Ajay Bhatia's latest patents is centered around fusion proteins and their use in the diagnosis and treatment of leishmaniasis. This invention involves a fusion protein made from a synthetic gene construct that includes elements derived from the antigens K26, K39, and K9. The fusion protein is particularly useful in diagnosing visceral leishmaniasis in animals, including humans and dogs. His innovative approach offers new opportunities for improving disease management and patient outcomes.
Career Highlights: Ajay Bhatia has had a distinguished career working with notable companies such as Corixa Corporation and the Infectious Disease Research Institute. His experience in these organizations has enabled him to develop groundbreaking inventions that address significant health challenges.
Collaborations: Throughout his career, Ajay has collaborated with various professionals, enhancing the scope and impact of his research. Notable coworkers include Peter Probst and Yasir A W Skeiky, with whom he has shared insights and worked diligently to promote innovative solutions in his field.
Conclusion: Ajay Bhatia exemplifies the spirit of innovation in the biotechnology sector. His extensive patent portfolio and collaborative efforts highlight his dedication to advancing medical science and improving the lives of patients affected by infectious diseases. With his ongoing contributions, the future of research and treatment options for leishmaniasis and other conditions looks promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile